Semaglutide and Patients Receiving Hemodialysis: Case Reports of Unexpected Benefits for Hyperphosphatemia and Hyperkalemia

Can J Hosp Pharm. 2024 May 8;77(2):e3534. doi: 10.4212/cjhp.3534. eCollection 2024.

Author

Affiliation

¹ , BSc, BScPharm, ACPR, PharmD, is with Sunnybrook Health Sciences Centre, Toronto, Ontario.

PMID: 38720915
PMCID: PMC11060791 (available on 2024-11-08)
DOI: 10.4212/cjhp.3534

No abstract available

Publication types

Case Reports